Navigation Links
ICSE China to Offer Inaugural Conference Programme in 2011

AMSTERDAM, May 2, 2011 /PRNewswire/ -- Leading events organiser UBM Live today announced details of the 2011 edition of ICSE China, which is dedicated to pharmaceutical contract services and outsourcing. ICSE, hosted from June 21-23, 2011 at the SNIEC China, is part of the most international pharmaceutical events line-up in China, which includes CPhI China for pharmaceutical ingredients, P-MEC China for pharma machinery and equipment, BioPh China for the biopharmaceuticals market and the new LABWorld pavilion for laboratory, analytical and biotechnology instrumentation technologies. Over 2,000 exhibitors and 27,000 visitors are expected over the three days. Attendance to the events is free through pre-registration at

"China's domestic market is expected to overtake Japan and become the world's second drug market by 2015(1)," noted Haf Cennydd, Brand Director, ICSE, P-MEC China and BioPh China. She further noted, "This continued growth has translated into continuously improving results for our events and has enabled us to constantly evolve our brands to reflect market trends. For this year's events we are excited to introduce a conference programme which will add even greater value for our visitors."

The inaugural China conference series, titled "Pharma R&D and Collaboration Strategies", will address global pharmaceutical issues, with an emphasis on China's pharma market, across key areas such as New Drug Discovery, Biopharm, Biosimilars, CRO/CMO, API Sourcing, Generics and Export Strategies and more. It will bring together Chinese and global pharma companies to explore different views regarding the China pharmaceutical market. Thirty eminent speakers from international pharmaceutical companies and research institutes, such as the FDA, Novartis, USP-China, Roche R&D Center, GSK China/HK, AstraZeneca Innovation Centre China, sanofi-aventis, REVA PHARMA, Dr. Reddy's and  Shanghai Pharma, will share their knowledge and research strategies. Additionally, in-depth case studies covering R&D and business development strategies will be presented by an outstanding panel of Chinese, Indian and international speakers from industry leading companies and associations.

The introduction of the conference programme to the China events follows the successful launch of a similar series at the CPhI Worldwide, CPhI South America and CPhI India events and is expected to draw over 400 attendees. The series will be offered in seven individually bookable 3-hour modules and further information can be found at:

ICSE China offers a meeting place for major Chinese contract research organizations (CRO) and contract manufacturing organizations (CMO). By partnering with the co-located events, ICSE looks to offer comprehensive industry access within the growing Chinese pharma market. Currently, contract services and outsourcing are booming sectors in the Chinese pharma market. Suppliers within this market have been able to successfully identify new areas for expansion in both the domestic and global markets and ICSE and co-located events provide face-to-face access to this growing market. The synergy between the events further serves to improve the visitor experience during the time spent in Shanghai.

The annual schedule of global ICSE events also includes ICSE Japan (13-15, July, 2011, Intex Osaka Exhibition Centre, Osaka, Japan), ICSE South America (24-26, August, 2011, Transamerica Expo Center, Sao Paola, Brazil), ICSE (25-27, October, Messe Frankfurt, Germany), and ICSE India (30 November – 2 December, 2011, Bombay Exhibition Centre, Mumbai, India). Further information about ICSE and its co-located events can be found online at,, and

(1) ARC China December 4, 2010 Newsletter

Notes for Editors:

  • With offices in the UK, Netherlands, USA, UAE and Brazil, UBM Live operates a number of market leading exhibitions, awards, websites/online products and publications in twenty different business sectors. UBM Live is part of UBM Ltd, a leading global media company listed on the London Stock Exchange.  See

  • UBM Ltd is a leading global business media company. We inform markets and bring the world's buyers and sellers together at events, online, in print and provide them with the information they need to do business successfully. Our 6,000 staff in more than 30 countries are organised into specialist teams that serve these communities, helping them to do business and their markets to work effectively and efficiently. See

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Transgenomic, Inc. Presents Its Latest Technology at the BIT Life Sciences World DNA and Genome Day Conference, Dalian, China
2. China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2011 on June 2, 2011
3. China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets
4. China Shenghuo Announces New Chief Financial Officer
5. Tens of thousands of buyers including Coles Group, El Corte Ingles, Kingfisher, Sears, The Home Depot and Tesco registered to attend China Sourcing Fairs
6. Medical Care Technologies Inc. Signs Letter of Intent for Joint Venture in China
7. China Botanic Pharmaceutical Provides Update on Badger Oil Sales
8. Varian Medical Systems to Exhibit the Latest Digital Image Detectors, X-Ray Tubes and Cancer Treatment Technologies at the CMEF Show in Shenzhen, China
9. Reportlinker Adds ENT Devices Market Outlook in China to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices
10. Canton Fair: Chinas Greatest Trade Fair to Open in April
11. China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures
Post Your Comments:
(Date:12/1/2015)... 01, 2015 ... the "Medium Molecular Weight Polyisobutylene Market ... Other Applications - Global Industry Analysis, Size, ... 2023" report to their offering. ... addition of the "Medium Molecular Weight ...
(Date:12/1/2015)... CLEVELAND , Dec. 1, 2015   ... innovation firm, today announced the publication of a ... Entering the Direct-to-Consumer Medical Market". The whitepaper gives ... roadmap for successfully penetrating this lucrative segment. ... purchase healthcare products to manage their own health, ...
(Date:12/1/2015)... 1, 2015 Array BioPharma Inc. ... its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public ... through a webcast on the Array BioPharma ... --> , ...
Breaking Medicine Technology:
(Date:12/1/2015)... (PRWEB) , ... December 02, 2015 , ... ... research “ Gastrointestinal events and association with initiation of treatment for osteoporosis ”. ... the use of pharmacological treatment in patients diagnosed with osteoporosis. Based on a ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... its acquisition by Jordan Industries International, LLC (“JII”). , With support from JII, ... and maintenance services to hospitals, surgery centers, clinics, research labs and medical facilities ...
(Date:12/1/2015)... ... , ... According to an article published on November 16th by ... U.S. Department of Health and Human Services, claiming that any states which do not ... clause in the law prohibiting the denial of coverage for pre-existing conditions. The article ...
(Date:12/1/2015)... ... December 01, 2015 , ... Baptist Medical Center Jacksonville ... is the only hospital in the region providing what is known as the ... pacing patients were revealed recently at a medical conference and published in The ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of ... has been named by MedEsthetics magazine as the Best Single Physician Practice in the ... the many elite aesthetic physicians honored by the industry publication. , Dr. Vitenas ...
Breaking Medicine News(10 mins):